Aptose Biosciences Inc. APTO NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • CA • USD

SharesGrow Score

46/100

2/5 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

Aptose Biosciences Inc. (APTO) — 分析師展望 / 分析師共識目標價為. 基於 11 位分析師評級, 共識為看漲 — 10 買入, 1 持有.

APTO 分析師評級

Buy

Ratings

10 買入

1 持有

基於過去3個月內 11 位分析師對 Aptose Biosciences Inc. 的評級

Rating breakdown

買入

10 91%

持有

1 9%

91%

買入

10 analysts

持有

1 analysts

賣出

0 analysts

其他人也在看

LBPH

Longboard Pharmaceuticals, Inc.

$59.98

+0.00%

CRVS

Corvus Pharmaceuticals, Inc.

CytomX Therapeutics, Inc.

$4.54

+3.42%

ASMB

Assembly Biosciences, Inc.

$29.44

+0.68%

SPRO

Spero Therapeutics, Inc.

$2.78

-0.36%

FBIOP

Fortress Biotech, Inc.

$13.37

-2.33%

GANX

Gain Therapeutics, Inc.

$1.89

+1.07%

Aptose Biosciences Inc. APTO NASDAQ

APTO 分析師評級

其他人也在看

獲取低估股票提醒